Soluble tumor necrosis factor receptor (p75) fusion protein (Enbrel) as a therapy for rheumatoid arthritis

Rheumatic Disease Clinics of North America

Volumn 24, Issue 3, 1998, Pages 579-591

  Moreland, L W ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE PHOSPHATE; CORTICOSTEROID; CYTOKINE; CYTOKINE ANTIBODY; DEXTROPROPOXYPHENE NAPSILATE; ETANERCEPT; FC RECEPTOR; GAMMA INTERFERON; HYBRID PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 2; INTERLEUKIN 4; LEUKEMIA INHIBITORY FACTOR; LYMPHOTOXIN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE; PARACETAMOL; PREDNISONE; PROTEINASE; RECEPTOR SUBTYPE; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTHRALGIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CYTOKINE PRODUCTION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG TARGETING; DRUG TOLERABILITY; ERYTHEMA; HUMAN; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; INJECTION SITE; INTRAVENOUS DRUG ADMINISTRATION; JOINT DESTRUCTION; MAINTENANCE THERAPY; NONHUMAN; PHARYNGITIS; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RASH; RECEPTOR AFFINITY; REVIEW; RHEUMATOID ARTHRITIS; RHINITIS; SINUSITIS; STRUCTURE ACTIVITY RELATION; SUBCUTANEOUS DRUG ADMINISTRATION; SYNOVIUM; UPPER RESPIRATORY TRACT INFECTION;

EID: 0031718315     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(05)70027-2     Document Type: Article

References (82)

1. D. Aderka H. Engelmann Y. Maor Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors J Exp Med 175 1992 323
2. D. Aderka A. Wysenbeek H. Engelmann Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus Arthritis Rheum 36 1993 1111
3. N. Ahmadzadeb M. Shingu M. Nobunaga The effect of recombinant tumor necrosis factor-alpha on superoxide and metalloproteinase production by synovial cells and chondrocytes Clin Exp Rheumatol 8 1990 387
4. T. Andus V. Gross A. Holstege High concentrations of soluble tumor necrosis factor receptors in ascites Hepatology 16 1992 749
5. R. Austgulen N.B. Liabakk E. Lien Increased levels of soluble tumor necrosis factor-alpha receptors in serum from pregnant women and in serum and urine samples from newborns Pediar Res 33 1993 82
6. D.W. Banner A. D'Arcy Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: Implications for TNF receptor activation Cell 73 1993 431
7. P. Barrera A.M. Boerbooms E.M. Janssen Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy Arthritis Rheum 36 1993 1070
8. P. Baumann R. Romero S. Berry Evidence of participation of the soluble tumor necrosis factor receptor I in the host response to intrauterine infection in preterm labor Am J Reprod Immunol 30 1993 184
9. M.H.A. Bemelmans J.W.M. Greve D.J. Gouma Increased concentrations of tumour necrosis factor (TNF) and soluble TNF receptors in biliary obstruction in mice: Soluble TNF receptors as prognostic factors for mortality Gut 38 1996 447
10. Beutler B. van Huffel C. Unraveling function in the TNF ligand and receptor families Science 264 1994 667
11. F.M. Brennan D. Chantry A. Jackson Inhibitory effects of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis Lancet 2 1989 244
12. F.M. Brennan M. Feldmann Cytokines in autoimmunity Curr Opinion Immunol 4 1992 754
13. M. Brockhaus Y. Bar-Khayim S. Gurwicz Plasma tumor necrosis factor soluble receptors in chronic renal failure Kidney Intern 42 1992 663
14. C.Q. Chu M. Field M. Feldmann Localization of tumor necrosis factor in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis Arthritis Rheum 34 1991 1125
15. A.P. Cope D. Aderka M. Doherty Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases Arthritis Rheum 35 1992 1160
16. A.P. Cope D.L. Gibbons D. Aderke Differential regulation of tumour necrosis factor receptors (TNF-R) by IL-4: Upregulation of p55 and p75 TNF-R on synovial joint mononuclear cells Cytokine 5 1993 205
17. A. Créange L. Bélec B. Clair Circulating rumor necrosis factor (TNF)-α and soluble TNF-α receptors in patients with Guillain-Barré syndrome J Neurol 68 1996 95
18. B.W. Deleuran C.Q. Chu M. Field Localization of tumor necrosis factor receptors in the synovial tissue and cartilage pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha Arthritis Rheum 35 1992 1170
19. W. Digel F. Porzsolt M. Schmid High levels of circulating soluble receptors for tumor necrosis factor in hairy cell leukemia and type B chronic lymphocytic leukemia J Clin Invest 89 1992 1690
20. J.D. Eason M. Pascual S. Wee Evaluation of recombinant human soluble dimeric tumor necrosis factor receptor for prevention of OKT3-associated acute clinical syndrome Transplantation 61 1996 224
21. M.J. Elliot R.N. Maini M. Feldmann Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to TNF-α Arthritis Rheum 36 1993 1681
22. M.J. Elliott R.N. Maini M. Feldmann Randomized double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor-α (cA2) versus placebo in rheumatoid arthritis Lancet 344 1994 1105
23. U. Elsasser-Beile H. Gallati W. Weber Increased plasma concentrations for type I and II tumor necrosis factor receptors and IL-2 receptors in cancer patients Tumor Biology 15 1994 17
24. A. Engel P. Kern W.V. Kern Levels of cytokines and cytokine inhibitors in the neutropenic patients with α-hemolytic streptococcus shock syndrome Clin Infect Dis 23 1996 785
25. Engelmann H. Aderka M. Rubinstein A tumor necrosis factor binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity J Biol Chem 264 1989 11974
26. D.T. Felson J.J. Anderson M. Boers The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials Arthritis Rheum 36 1993 729
27. A. Ferrante B. Hauptmann P. Seckinger Inhibition of tumour necrosis factor alpha (TNF-α)-induced neutrophil respiratory burst by a TNF inhibitor Immunology 72 1991 440
28. Fisher C.J. Jr S.M. Opal J.F. Dhainaut Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group Crit Care Med 21 1993 318
29. A.H. Froon M.H. Bemelmans J.W. Greve Increased plasma concentrations of soluble tumor necrosis factor receptors in sepsis syndrome: Correlation with plasma creatinine values Critical Care Med 22 1994 803
30. S. Furukawa T. Masubara Y. Umezawa Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease Pediatrics 124 1994 721
31. C. Gabay N. Cakir F. Moral Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlated with disease activity J Rheumatol 24 1997 303
32. T. Gatanaga C.D. Hwang W. Kohr Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients Proc Natl Acad Sci USA 87 1990 8781
33. E. Girardin P. Roux-Lombard G.E. Grau Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. The J5 Study Group Immunology 76 1992 20
34. C. Haworth F.M. Brennan D. Chantry Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: Regulation by tumor necrosis-alpha Eur J Immunol 21 1991 2575
35. B. Heilig C. Fiehn M. Brockhaus Evaluation of soluble tumor necrosis factor (TNF) receptors and TNF receptor antibodies in patients with systemic lupus erythematodes, progressive systemic sclerosis, and mixed connective tissue disease J Clin Immunol 13 1993 321
36. T. Hino H. Nakamura Y. Shibata Elevated levels of type II soluble tumor necrosis factor receptors in the bronchoalveolar lavage fluids of patients with sarcoidosis Lung 175 1997 187
37. M.C. Hochberg R.W. Chang I. Dwosh American College of Rheumatology, 1991, revised criteria for the classification of global functional status in rheumatoid arthritis Arthritis Rheum 35 1992 498
38. T. Ichiyama T. Hayashi M. Nishikawa Cerebrospinal fluid levels of soluble tumour necrosis factor receptor in acute encephalitis J Neurol 243 1996 457
39. L.A.B. Joosten M.M.A. Helsen van de Loo F.A.J. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: A comparative study using anti-TNFα, anti-IL-1α/β, and IL-1Ra Arthritis Rheum 39 1996 797
40. A.F. Kavanaugh J.J. Cush St Clair E.W. Anti-TNF monoclonal antibody (Mab) treatment of rheumatoid arthritis (RA) patients with active disease on methotrexate (MTX): Results of a double-blind, placebo controlled multicenter trial [abstract] Arthritis Rheum 39 Suppl 1996 123
41. J. Keffer L. Probert H. Cazlaris Transgenic mice expressing human tumour necrosis factor: A predictive genetic model of arthritis EMBO Journal 10 1991 4025
42. H. Kobayashi J. Fukata N. Murakami Tumor necrosis factor receptors in the pituitary cells Brain Research 758 1997 45
43. T. Kraus A. Mehrabi J. Arnold Evaluation of soluble tumor necrosis factor receptors with orthotopic liver transplantation Transplant Proc 24 1992 2539
44. Kuiper S, Joosten LAB, Bendele AM, et al: Different roles of tumor necrosis factor-α and interleukin-1 in murine streptococcal cell wall arthritis. Cytokine, in press
45. M.J. Kupfermine A.M. Peaceman D. Aderka Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia Obstet Gynecol 88 1996 420
46. M. Lantz F. Bjornberg I. Olsson Adherence of neutrophils induces release of soluble tumor necrosis factor receptor forms J Immunol 152 1994 1362
47. R. Lucas J. Lou D.R. Morel TNF receptors in the microvascular pathology of acute respiratory distress syndrome and cerebral malaria J Leukoc Biol 61 1997 551
48. K.L. MacNaul N. Chartrain M. Lark Differential effects of IL-1 and TNF alpha on the expression of stromelysin, collagenase and then natural inhibitor, TIMP, in rheumatoid synovial fibroblasts Matrix 1 suppl 1992 198
49. R.N. Maini F.C. Breedveld J.R. Kalden Low dose methotrexate (MTX) suppresses anti-globulin responses and potentiates efficacy of a chimeric monoclonal anti-TNF antibody (cA2) given repeatedly in rheumatoid arthritis (RA) [abstract] Arthritis Rheum 40 suppl 1997 126
50. J. Messer D. Eyer L. Donato Evaluation of interleukin-6 and soluble receptors of tumor necrosis factor for early diagnosis of neonatal infection J Pediatr 129 1996 574
51. K.M. Mohler D.S. Torrance C.A. Smith Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists J Immunol 151 1993 1548
52. L.W. Moreland S.W. Baumgartner M.H. Schiff Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein N Eng J Med 337 1997 141
53. L.W. Moreland G.R. Margolies L.W. Heck Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: Toxicity and dose finding trial in refractory rheumatoid arthritis J Rheumatol 23 1996 1849
54. R.B. Moser B. Schleiffenbaum P. Groscurth Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage J Clin Invest 83 1989 444
55. M.H. Nam D. Reda S. Boujouko Recombinant human chimeric tumor necrosis factor (TNF) receptor (TNFR:Fc): Safety and pharmacokinetics in humans [abstract] Clin Res 41 1993 249A
56. I. Olsson M. Lantz E. Nilsson Isolation and characterization of a tumor necrosis factor binding protein from urine Eur J Haematol 42 1989 270
57. D. Pennica V.T. Lam N.K. Mize Biochemical properties of the 75-kDa tumor necrosis factor receptor: Characterization of ligand binding, internalization, and receptor phosphorylation J Bio Chem 267 1992 21172
58. P.F. Piguet G.E. Grau C. Vesin Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor Immunology 77 1992 510
59. E.C.C. Rankin E.H.S. Choy D. Kassimos Therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis Br J Rheumatology 34 1995 334
60. G.P. Rizzardi W. Barcellini G. Tambussi Plasma levels of soluble CD30, tumour necrosis factor (TNF)-α and TNF receptors during primary HIV-1 infection: Correlation with HIV-1 RNA and the clinical outcome AIDS 10 1996 45 50
61. P. Roux-Lombard L. Punzi F. Hasler Soluble tumor necrosis receptors in human inflammatory synovial fluids Arthritis Rheum 36 1993 485
62. Saxne T. Palladino M.A. Jr D. Heinegard Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum Arthritis Rheum 31 1988 1041
63. J. Schneider F.M. Hofman M.L. Apuzzo Cytokines and immunoregulatory molecules in malignant glial neoplasms J Neurosurg 77 1992 265
64. P. Seckinger J. Zhang B. Hauptmann Characterization of a tumor necrosis factor a (TNF-α) inhibitor: Evidence of immunological cross-reactivity with the TNF receptor Proc Natl Acad Sci USA 87 1990 5188
65. M. Shingu Y. Nagai T. Isayama The effects of cytokines on metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes and TIMP production by synovial cells and endothelial cells Clin Exp Immunol 94 1993 145
66. G.A. Spinas U. Keller M. Brockhaus Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia J Clin Invest 90 1992 533
67. L.A. Tartaglia R.F. Weber I.S. Figari The two different receptors for tumor necrosis factor mediate distinct cellular responses Proc Natl Acad Sci USA 88 1991 9292
68. D.J. Taylor Cytokine combinations increase p75 tumor necrosis factor receptor binding and stimulate receptor shedding in rheumatoid synovial fibroblasts Arthritis Rheum 37 1994 232
69. H. Tilg L. Shapiro M.B. Atkins Induction of circulating and erythrocyte-bound IL-8 by IL-2 immunotherapy and suppression of its in vitro production by IL-1 receptor antagonist and soluble tumor necrosis factor receptor (p75) chimera J Immunol 151 1993 3299
70. N. Tsukada M. Matsuda K. Miyagi Increased levels of intercellular adhesion molecule-1 (ICAM-1) and tumor necrosis factor receptor in the cerebrospinal fluid of patients with multiple sclerosis Neurology 43 1993 2679
71. van de Loo F.A. L.A. Joosten van Lent P.L. Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis Arthritis Rheum 38 1995 164
72. J.L. Vincent J. Bakker G. Marecaux Administration of anti-TNF antibody improves left ventricular function in septic shock patients. Results of a pilot study Chest 101 1992 810
73. R.A. Ward L. Gordan Soluble tumor necrosis factor receptors are increased in hemodialysis patients ASAIO Journal 39 1993 782 786
74. K. Warzacha G. Salles J. Bienvenu Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients J Clin Oncol 15 1997 499
75. M. Weinblatt L.W. Moreland M.H. Schiff Longterm and phase III treatment of DMARD failing rheumatoid arthritis patients with TNF receptor p75 Fc fusion protein (TNFR:Fc; Enbrel™ [abstract] Arthritis Rheum 40 suppl 1997 126
76. C.I. Westacott R.M. Atkins P.A. Dieppe Tumor necrosis factor-a receptor expression on chondrocytes isolated from human articular cartilage J Rhematol 21 1994 1710
77. R.O. Williams J. Chrayeb M. Feldman Successful therapy of collagen-induced arthritis with TNF receptor-IgG fusion protein and combination with anti-CD-4 Immunology 84 1995 433
78. R.O. Williams M. Feldmann R.N. Maini Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis Proc Nat Acad Sci USA 89 1992 9784
79. R.O. Williams L.J. Mason M. Feldmann Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis Proc Nat Acad Sci USA 91 1994 2767
80. P.H. Wooley J. Dutcher M.B. Widmer Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice J Immunol 11 1993 6602
81. S. Yoshida S. Hashimoto T. Nakayama Elevation of serum soluble tumour necrosis factor (TNF) receptor and IL-1 receptor antagonist levels in bronchial asthma Clin Ep Immunol 106 1996 73
82. R. Zangerle H. Gallati M. Sarcletti Increased serum concentrations of soluble tumor necrosis factor receptors in HIV-infected individuals are associated with immune activation J AIDS 7 1994 79